Safety and immunogenicity of heterologous Ad26.ZEBOV and MVA-BN®-Filo prime-boost Ebola vaccines: 6-month follow-up of a Phase I randomized trial in healthy adults

• Main Authors: Macaya Douoguih (Author), Neil Goldstein (Author), Stephan Bart (Author), Kerstin Luhn (Author), Wilbert Van Duijnhoven (Author), Carla Truyers (Author), Benoit Callendret (Author)
• Format: Book
• Published: Elsevier, 2016-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Item Description

2055-6640
10.1016/S2055-6640(20)31129-8